Home / Research library / Glutathione
Glutathione: molecular data, studies & sources
Glutathione is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C10H17N3O6S
- Molecular weight (MW)
- 307.33 g/mol
- PubChem compound ID
- 124886
- Record title
- Glutathione
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 124886 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid
- InChIKey
- RWSXRVCMGQZWBV-WDSKDSINSA-N
- SMILES
- C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N
Calculated molecular descriptors
| Monoisotopic (exact) mass | 307.0838 Da |
|---|---|
| Heavy atoms | 20 |
| Hydrogen-bond donors | 6 |
| Hydrogen-bond acceptors | 6 |
| Rotatable bonds | 9 |
| Topological polar surface area | 158.8 Ų |
| Calculated logP (Crippen) | -2.21 |
| Rings | 0 |
| Stereocenters | 2 |
| Formal charge | 0 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list Glutathione as an intervention. Studies that only measure the molecule as a biomarker are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
40 registered studies matched, 11 currently active or recruiting.
| Study | Phase · status | Conditions | Sponsor · size |
|---|---|---|---|
| Pharmacodynamics & Pharmacokinetics Study of S-Acetyl Glutathione in Highly Trained Soccer PlayersNCT07690124 · start 2026-09-01 · primary completion 2026-12-20 | Not applicableNot Yet Recruiting | Performance Recovery · Exercise-induced Inflammation · Exercise-induced Oxidative Stress | University of Thessaly20 participants |
| Greater Atlanta Integrative Pediatrics Autism Spectrum Disorder Research StudyNCT07622316 · start 2026-06-01 · primary completion 2026-12-31 | Phase 1Recruiting | Autism Spectrum Disorder · Autism · ASD · Autism Spectrum Disorder (ASD) | Greater Atlanta Integrative Pediatrics100 participants |
| Adia Med of Winter Park LLC Chronic Kidney Disease Research StudyNCT07572890 · start 2026-05-18 · primary completion 2028-01 | Phase 1Recruiting | Chronic Kidney Disease · Kidney Disease · Kidney Disease, Chronic · Chronic Kidney Disease (CKD) · CKD | Adia Med of Winter Park LLC100 participants |
| Adia MED of Winter Park LLC Autism Spectrum Disorder Research StudyNCT07304440 · start 2026-05-01 · primary completion 2028-06-15 | Phase 1Recruiting | Autism Spectrum Disorder · Autism · ASD · Autism Spectrum Disorder (ASD) | Adia Med of Winter Park LLC100 participants |
| Evaluation of the Efficacy and Safety of Oral Tranexamic Acid Combined With Glutathione-assisted Microneedling Versus Each Therapy Alone in the Treatment of MelasmaNCT07448415 · start 2026-02 · primary completion 2027-02 | Phase 2 / Phase 3Not Yet Recruiting | Melasma | Assiut University42 participants |
| Efficacy Evaluation Study of Vitamin C and Glutathione Liquid SachetNCT07379216 · start 2026-01-24 · primary completion 2026-05-18 | Not applicableRecruiting | Skin Condition · Anti-Oxidative Stress | TCI Co., Ltd.30 participants |
| Gingival Hyperpigmentation Treatment With Injectable Vitamin C in Conjunction With Glutathione Versus The Conventional Surgical Depigmentation: A Randomized Controlled Clinical TrialNCT07595705 · start 2025-08-01 · primary completion 2027-01 | Phase 2Recruiting | Gingival Pigmentation · Depigmentation · Vitamin C · Glutathione | Cairo University30 participants |
| Efficacy and Safety of Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia: A Multicenter Randomized Controlled TrialNCT06922669 · start 2025-06-24 · primary completion 2027-03-31 | Not applicableRecruiting | Drug Induced Liver Injury | General Hospital of Shenyang Military Region232 participants |
| Prospective, Randomized Controlled Clinical Trial of Glutathione Combined With PD-1 Antibody and Chemotherapy in Patients With Advanced Non-Small Cell Lung CancerNCT06896422 · start 2025-06-01 · primary completion 2026-12-31 | Phase 1Recruiting | Non-Small Cell Lung Cancer · Chemotherapy · PD1 Antibody · Glutathione | The First Affiliated Hospital of Zhengzhou University80 participants |
| Clinical Trial on the Efficacy and Safety of Ultrasound-Enhanced Delivery of Compound Tranexamic Acid Solution in the Treatment of MelasmaNCT07202156 · start 2024-10-20 · primary completion 2026-02-07 | Not applicableRecruiting | Melasma (Facial Melasma) | The First Affiliated Hospital with Nanjing Medical University35 participants |
Show 30 more registered studies
| Study | Phase · status | Conditions | Sponsor · size |
|---|---|---|---|
| Efficacy of Mitochondrial Directed Therapy in Prevention of Cardiac Surgery Associated AKI Prevent Cardiac Surgery Associated AKI Trial (Prevent CSA-AKI Trial)NCT06620523 · start 2024-07-18 · primary completion 2027-06-17 | Phase 2Recruiting | Renal Failure · Coronary Artery Disease · Surgery · Surgery-Complications | George Washington University242 participants |
| A Randomized, Double-Blind, Placebo-Controlled, Two-Arms, Prospective, Single-Center Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Test Product i.e. Oziva Bioactive Gluta Fizzy in Subjects With Facial HyperpigmentationNCT07162623 · start 2025-09-02 · primary completion 2026-04-15 | Not applicableCompleted | Hyperpigmentation | NovoBliss Research Pvt Ltd62 participants |
| Comparison of Gingival Depigmentation Using Microneedling and Microneedling With Glutathione Gel - A Split Mouth Clinical TrialNCT07748507 · start 2025-06-25 · primary completion 2025-12-28 | Not applicableCompleted | Gingiival Hyperpigmentation | Krishnadevaraya College of Dental Sciences & Hospital15 participants |
| The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19NCT05371288 · start 2025-06 · primary completion 2025-09 | Early phase 1Withdrawn | COVID-19 | University of California, IrvineEnrollment not listed |
| The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled StudyNCT06313164 · start 2023-06-20 · primary completion 2024-01-30 | Not applicableCompleted | Type 2 Diabetes | S.LAB (SOLOWAYS)217 participants |
| Bioavailable Glutathione Supplementation: During Hospitalization and BeyondNCT03166371 · start 2022-02 · primary completion 2023-02 | Not applicableWithdrawn | Malnutrition | Emory UniversityEnrollment not listed |
| Effect of Glutathione vs Potassium Iodide in Reducing Silver Diamine Flouride Staining When Used in Treatment of Primary Carious TeethNCT04816487 · start 2021-05-01 · primary completion 2021-08-01 | Not applicableUnknown | Discoloration, Tooth | Cairo University60 participants |
| Evaluation of the Relationship Between the Psychological Level of Stress, Serum Oxidative Stress, Follicular Fluid Oxidative Stress, Ovarian Hormones and Response to Gonadotropin Stimulation During IVF (in Vitro Fertilisation) Procedures.NCT05575739 · start 2021-02-14 · primary completion 2022-12-31 | Not applicableUnknown | IVF · Pregnancy · Oxidative Stress · Fertility Disorders | Calla IVF Center80 participants |
| Effects of the "Glutathione Support for Health (GSH)" Plan on Glutathione Status in Type 2 DiabetesNCT04386187 · start 2020-07-28 · primary completion 2021-04-02 | Not applicableCompleted | Type 2 Diabetes | University of California, San Diego12 participants |
| Effects of 4 Weeks Supplementation With L-Citrulline and Glutathione on Arterial Function and Cardiovascular Responses in Postmenopausal Healthy Women: A Pilot StudyNCT04672447 · start 2020-07-01 · primary completion 2022-04-27 | Not applicableCompleted | Menopause · Cardiovascular Risk Factor | Texas Tech University39 participants |
| Association of Extracellular Thiol-disulfide and Intracellular Oxidized-reduced Glutathione Homeostasis With Severity and Clinical Prognosis of Post-stroke PatientsNCT04884555 · start 2020-07-01 · primary completion 2021-01-01 | Not applicableCompleted | Stroke | Abant Izzet Baysal University77 participants |
| Efficacy and Safety of Combined Microneedling With Topical Glutathione Versus Carboxy Therapy in Treatment of Patients With Periorbital HyperpigmentationNCT04389788 · start 2020-02-12 · primary completion 2020-10-10 | Not applicableCompleted | Periorbital Hypermelanosis | Sohag University31 participants |
| An Open-Label Study of Glutathione in Children With Autism Spectrum DisorderNCT05954052 · start 2019-07-01 · primary completion 2023-08-15 | Phase 4Terminated | Autism Spectrum Disorder | University of Chicago6 participants |
| Oral Glutathione As A Skin Whitening Agent: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical TrialNCT04105504 · start 2018-04-08 · primary completion 2018-06-06 | Phase 1Completed | Glutathione · Skin Whitening | Dr Irma Bernadette S Sitohang90 participants |
| Testing the Model: A Phase I/II Randomized Double Blind Placebo Control Trial of Targeted Therapeutics: Liposomal Glutathione and CurcuminNCT02848417 · start 2016-04 · primary completion 2019-08 | Phase 1 / Phase 2Unknown | Gulf War Syndrome | South Florida Veterans Affairs Foundation for Research and Education75 participants |
| A Multicenter Randomized Controlled Trial to Compare the Efficacy of End-ischemic Dual Hypothermic Oxygenated Perfusion With Standard Static Cold Storage of Liver Grafts Donated After Circulatory Death in Preventing Biliary ComplicationsNCT02584283 · start 2016-01 · primary completion 2020-01 | Phase 3Completed | Liver Failure · End Stage Liver Disease · Biliary Tract Diseases | Robert J. Porte157 participants |
| Oral Glutathione Supplementation on Cold/Flu Symptoms in Older Healthy AdultsNCT02316925 · start 2015-05 · primary completion 2015-05 | Not applicableWithdrawn | Improvement in Immune Cell Function in Elderly Humans | University of FloridaEnrollment not listed |
| Phase IIb Study of Intranasal Glutathione in Parkinson's DiseaseNCT02424708 · start 2015-04 · primary completion 2016-03 | Phase 2Completed | Parkinson's Disease | Bastyr University45 participants |
| Central Nervous System Uptake of Intranasal Glutathione in Parkinson's DiseaseNCT02324426 · start 2014-12 · primary completion 2015-03 | Phase 1Completed | Parkinson's Disease | University of Washington15 participants |
| Pilot Study of Oral Liposomal Glutathione Supplementation on Levels of Glutathione in Blood and Biomarkers of Oxidative Stress and Immune Function in Healthy AdultsNCT02278822 · start 2014-11 · primary completion 2015-04 | Not applicableCompleted | Healthy | Milton S. Hershey Medical Center12 participants |
| Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL): a First-in-men StudyNCT02251041 · start 2014-09 · primary completion 2019-02 | Phase 2Completed | Reperfusion Injury | Universitaire Ziekenhuizen KU Leuven143 participants |
| Biological Evaluation of Dietary Supplement Liposomal GlutathioneNCT01967667 · start 2014-04 · primary completion 2021-02 | Not applicableCompleted | Schizophrenia | University of Maryland, Baltimore11 participants |
| Oral Glutathione and Health Outcomes Among Persons With Post-Polio SyndromeNCT01402570 · start 2011-08 · primary completion 2013-04 | Not applicableCompleted | Post-polio Syndrome · Physical Activity · Depression · Pain · Sleep Disorders | University of Michigan20 participants |
| Effects of GSH and N-Acetylcysteine on Inflammatory Markers Among Adults With CVD RiskNCT01550432 · start 2011-06 · primary completion 2012-07 | Not applicableCompleted | Obesity · Hyperlipidemia · Insulin Resistance · Hypertension | Stanford University78 participants |
| Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis for Growth FailureNCT02029521 · start 2011-03 · primary completion 2012-03 | Not applicableCompleted | Cystic Fibrosis | Clark Bishop47 participants |
| Randomized, Single Blind, Controlled Trial of Inhaled Glutathione Versus Placebo in Patients With Cystic FibrosisNCT01450267 · start 2010-06 · primary completion 2012-05 | Phase 3Unknown | Cystic Fibrosis | Serafino A. Marsico150 participants |
| Polymorphism of Oxidative Stress Relative Genes in Contrast Medium Induced Nephropathy:Implications in the Pathogenesis and the Effect of Antioxidant prevention-a Prospective,Randomized,Controlled StudyNCT01142024 · start 2010-03 · primary completion 2011-03 | Not applicableCompleted | Nephropathy · Oxidative Stress | Huashan Hospital1000 participants |
| The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled StudyNCT02311907 · start 2009-12 · primary completion 2012-08 | Phase 3Completed | Chemotherapeutic Agent Toxicity · Neuropathy · Neurotoxicity Syndrome · Pain · Stage IIIA Fallopian Tube Cancer · Stage IIIA Ovarian Cancer | Alliance for Clinical Trials in Oncology195 participants |
| Double-Blind, Placebo-Controlled, Crossover Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior ProblemsNCT00889538 · start 2009-04 · primary completion 2012-09 | Not applicableCompleted | Autism · Severe Behavior Disorder | University of Louisville24 participants |
| Glutathione as an Oral Whitening Agent: a Randomized, Double-blind, Placebo-controlled StudyNCT01016080 · start 2009-02 · primary completion 2009-05 | Phase 1Completed | Skin Whitening | Chulalongkorn University60 participants |
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human and clinical studies
Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.
- Human study · PubMed trial index
Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study.
Arjinpathana N, Asawanonda P · The Journal of dermatological treatment · 2012
PMID 20524875 · DOI: 10.3109/09546631003801619
- Human study · PubMed trial index
Randomized controlled trial of oral glutathione supplementation on body stores of glutathione.
Richie JP, Nichenametla S, Neidig W et al. · European journal of nutrition · 2015
PMID 24791752 · DOI: 10.1007/s00394-014-0706-z
- Human study · PubMed trial index
Effectiveness of oral glutathione in reducing nitric oxide and IL-1α concentrations for clinical improvement in mild to moderate acne vulgaris: a randomized controlled trial.
Mawu FO, Anwar AI, Djawad K et al. · Acta dermatovenerologica Alpina, Pannonica, et Adriatica · 2025
PMID 41014073
- Human study · PubMed trial index
Topical glutathione amino acid precursors protect skin against environmental and oxidative stress.
Cui X, Mi T, Xiao X et al. · Journal of the European Academy of Dermatology and Venereology : JEADV · 2024
PMID 38189670 · DOI: 10.1111/jdv.19717
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Research publication · design requires review
The antioxidant glutathione.
Averill-Bates DA · Vitamins and hormones · 2023
PMID 36707132 · DOI: 10.1016/bs.vh.2022.09.002
- Review · secondary evidence
Glutathione as a skin-lightening agent and in melasma: a systematic review.
Sarkar R, Yadav V, Yadav T et al. · International journal of dermatology · 2025
PMID 39444151 · DOI: 10.1111/ijd.17535
- Review · secondary evidence
The Glutathione Theory of Aging.
Pelton R · Alternative therapies in health and medicine · 2024
PMID 39316535
Glutathione supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Glutathione for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| American PeptidesUSD | 600mg Vial · 1500mg Vial · 500mg Spray3 recorded offers | 500mg Spray · $90.00Checked Oct 7, 2026Supplier listing |
| Blank PeptidesUSD | 1500mg Vial · 500mg Vial2 recorded offers | 1500mg Vial · $110.00Stale observation · Recorded out of stock · Checked Sep 30, 2026Supplier listing |
| Amino ClubUSD | 1500mg Vial1 recorded offers | 1500mg Vial · $59.99Stale observation · Checked Sep 28, 2026Supplier listing |
| Amino USAUSD | 600mg Vial1 recorded offers | 600mg Vial · $50.00Checked Oct 7, 2026Supplier listing |
| Cenexa LabsUSD | 1500mg Vial1 recorded offers | 1500mg Vial · $89.09Checked Oct 7, 2026Supplier listing |
Reference sources & further reading
- PubChem compound record 124886 — chemical identity and structure.
- Wikipedia: Glutathione — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
5-Amino-1MQ
C10H11N2+
159.21 g/mol · PubChem CID 950107
0 selected publications · 0 human study records
FOXO4-DRI
C228H388N86O64
5358 g/mol · PubChem CID 167312269
4 selected publications · 0 human study records
GHK-Cu
C14H23CuN6O4+
402.92 g/mol · PubChem CID 71587328
1 selected publications · 0 human study records · 1 registered trials
Humanin
C119H204N34O32S2
2687.2 g/mol · PubChem CID 16131438
1 selected publications · 1 human study records
L-Carnitine
Molecular identity needs further verification
8 selected publications · 0 human study records · 40 registered trials
MOTS-c
C101H152N28O22S2
2174.6 g/mol · PubChem CID 146675088
6 selected publications · 3 human study records · 1 registered trials